I think that we have insight on current big pharma demands through Axel Hoos who is lead for oncology acquisitions for GSK. He is non-executive director lurking in the background.
-
- There are more pages in this discussion • 6,703 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(13.6%) |
Mkt cap ! $93.33M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $587.3K | 47.60M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 8127618 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3597845 | 27 |
View Market Depth
| Last trade - 15.13pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |